• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用大规模共价虚拟筛选发现免疫蛋白酶体抑制剂。

Discovery of Immunoproteasome Inhibitors Using Large-Scale Covalent Virtual Screening.

机构信息

Medicinal Chemistry Research Group, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Magyar tudósok krt. 2, H-1117 Budapest, Hungary.

Faculty of Pharmacy, University of Ljubljana, Aškerčeva cesta 7, SI-1000 Ljubljana, Slovenia.

出版信息

Molecules. 2019 Jul 16;24(14):2590. doi: 10.3390/molecules24142590.

DOI:10.3390/molecules24142590
PMID:31315311
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6680723/
Abstract

Large-scale virtual screening of boronic acid derivatives was performed to identify nonpeptidic covalent inhibitors of the β5i subunit of the immunoproteasome. A hierarchical virtual screening cascade including noncovalent and covalent docking steps was applied to a virtual library of over 104,000 compounds. Then, 32 virtual hits were selected, out of which five were experimentally confirmed. Biophysical and biochemical tests showed micromolar binding affinity and time-dependent inhibitory potency for two compounds. These results validate the computational protocol that allows the screening of large compound collections. One of the lead-like boronic acid derivatives identified as a covalent immunoproteasome inhibitor is a suitable starting point for chemical optimization.

摘要

采用大规模虚拟筛选硼酸衍生物的方法,以鉴定免疫蛋白酶体β5i 亚基的非肽共价抑制剂。采用包含非共价和共价对接步骤的分层虚拟筛选级联,对超过 104000 种化合物的虚拟库进行了筛选。然后,从 32 个虚拟命中物中选择了 5 个进行实验验证。生物物理和生化测试表明,两种化合物具有微摩尔结合亲和力和时间依赖性抑制效力。这些结果验证了可以筛选大型化合物库的计算方案。鉴定出的一种类似先导的硼酸衍生物作为共价免疫蛋白酶体抑制剂,是进行化学优化的合适起点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02fe/6680723/60349271e976/molecules-24-02590-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02fe/6680723/3723f6b548ea/molecules-24-02590-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02fe/6680723/f7345132a42c/molecules-24-02590-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02fe/6680723/71ecf6c03d44/molecules-24-02590-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02fe/6680723/60349271e976/molecules-24-02590-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02fe/6680723/3723f6b548ea/molecules-24-02590-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02fe/6680723/f7345132a42c/molecules-24-02590-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02fe/6680723/71ecf6c03d44/molecules-24-02590-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02fe/6680723/60349271e976/molecules-24-02590-g004.jpg

相似文献

1
Discovery of Immunoproteasome Inhibitors Using Large-Scale Covalent Virtual Screening.利用大规模共价虚拟筛选发现免疫蛋白酶体抑制剂。
Molecules. 2019 Jul 16;24(14):2590. doi: 10.3390/molecules24142590.
2
Virtual Screening Strategy and In Vitro Tests to Identify New Inhibitors of the Immunoproteasome.虚拟筛选策略及体外试验鉴定免疫蛋白酶体新型抑制剂
Int J Mol Sci. 2023 Jun 22;24(13):10504. doi: 10.3390/ijms241310504.
3
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors.鉴定2-硫代咪唑烷-4-酮衍生物为新型非共价蛋白酶体和免疫蛋白酶体抑制剂。
Bioorg Med Chem Lett. 2018 Feb 1;28(3):278-283. doi: 10.1016/j.bmcl.2017.12.053. Epub 2017 Dec 26.
4
Nonpeptidic Selective Inhibitors of the Chymotrypsin-Like (β5 i) Subunit of the Immunoproteasome.无肽类免疫蛋白酶体糜蛋白酶样(β5i)亚单位选择性抑制剂。
Angew Chem Int Ed Engl. 2016 May 4;55(19):5745-8. doi: 10.1002/anie.201600190. Epub 2016 Apr 1.
5
Optimization of α-amido boronic acids via cryo-electron microscopy analysis: Discovery of a novel highly selective immunoproteasome subunit LMP7 (β5i)/LMP2 (β1i) dual inhibitor.通过冷冻电子显微镜分析优化α-酰胺基硼酸:发现一种新型高选择性免疫蛋白酶体亚基LMP7(β5i)/LMP2(β1i)双重抑制剂。
Bioorg Med Chem. 2024 Jul 15;109:117790. doi: 10.1016/j.bmc.2024.117790. Epub 2024 Jun 12.
6
Identification of noncovalent proteasome inhibitors with high selectivity for chymotrypsin-like activity by a multistep structure-based virtual screening.通过基于结构的多步虚拟筛选鉴定对胰凝乳蛋白酶样活性具有高选择性的非共价蛋白酶体抑制剂。
Eur J Med Chem. 2016 Oct 4;121:578-591. doi: 10.1016/j.ejmech.2016.05.049. Epub 2016 May 27.
7
Fragment-Sized and Bidentate (Immuno)Proteasome Inhibitors Derived from Cysteine and Threonine Targeting Warheads.基于半胱氨酸和苏氨酸的片段大小和双齿(免疫)蛋白酶体抑制剂靶向弹头。
Cells. 2021 Dec 6;10(12):3431. doi: 10.3390/cells10123431.
8
Discovery of novel covalent proteasome inhibitors through a combination of pharmacophore screening, covalent docking, and molecular dynamics simulations.通过药效团筛选、共价对接和分子动力学模拟相结合的方法发现新型共价蛋白酶体抑制剂。
J Mol Model. 2014 Nov;20(11):2515. doi: 10.1007/s00894-014-2515-y. Epub 2014 Nov 14.
9
Selective immunoproteasome inhibitors with non-peptide scaffolds identified from structure-based virtual screening.通过基于结构的虚拟筛选鉴定出的具有非肽骨架的选择性免疫蛋白酶体抑制剂。
Bioorg Med Chem Lett. 2014 Aug 1;24(15):3614-7. doi: 10.1016/j.bmcl.2014.05.025. Epub 2014 May 17.
10
Design, synthesis and docking studies of novel dipeptidyl boronic acid proteasome inhibitors constructed from αα- and αβ-amino acids.由αα-和αβ-氨基酸构建的新型二肽基硼酸蛋白酶体抑制剂的设计、合成与对接研究
Bioorg Med Chem Lett. 2016 Apr 15;26(8):1958-62. doi: 10.1016/j.bmcl.2016.03.007. Epub 2016 Mar 3.

引用本文的文献

1
Targeting Microglial Immunoproteasome: A Novel Approach in Neuroinflammatory-Related Disorders.靶向小胶质细胞免疫蛋白酶体:神经炎症相关疾病的一种新方法。
ACS Chem Neurosci. 2024 Jul 17;15(14):2532-2544. doi: 10.1021/acschemneuro.4c00099. Epub 2024 Jul 6.
2
Docking covalent targets for drug discovery: stimulating the computer-aided drug design community of possible pitfalls and erroneous practices.药物发现中的对接共价靶标:激发计算机辅助药物设计社区注意可能的陷阱和错误做法。
Mol Divers. 2023 Aug;27(4):1879-1903. doi: 10.1007/s11030-022-10523-4. Epub 2022 Sep 4.
3
Identification of Novel Covalent XPO1 Inhibitors Based on a Hybrid Virtual Screening Strategy.

本文引用的文献

1
A Practical Review of Proteasome Pharmacology.蛋白酶体药理学实用综述。
Pharmacol Rev. 2019 Apr;71(2):170-197. doi: 10.1124/pr.117.015370.
2
Structural and Antiviral Studies of the Human Norovirus GII.4 Protease.人诺如病毒 GII.4 蛋白酶的结构和抗病毒研究。
Biochemistry. 2019 Feb 19;58(7):900-907. doi: 10.1021/acs.biochem.8b01063. Epub 2019 Jan 16.
3
Discovery of covalent enzyme inhibitors using virtual docking of covalent fragments.使用共价片段的虚拟对接发现共价酶抑制剂。
基于混合虚拟筛选策略鉴定新型的 XPO1 共价抑制剂。
Molecules. 2022 Apr 14;27(8):2543. doi: 10.3390/molecules27082543.
4
A Nut for Every Bolt: Subunit-Selective Inhibitors of the Immunoproteasome and Their Therapeutic Potential.一“螺母”配一“螺栓”:免疫蛋白酶体的亚基选择性抑制剂及其治疗潜力。
Cells. 2021 Jul 29;10(8):1929. doi: 10.3390/cells10081929.
5
Synthesis and Biochemical Evaluation of Warhead-Decorated Psoralens as (Immuno)Proteasome Inhibitors.弹头修饰的补骨脂素的合成与生化评价作为(免疫)蛋白酶体抑制剂。
Molecules. 2021 Jan 12;26(2):356. doi: 10.3390/molecules26020356.
6
Structure-Based Design of Biologically Active Compounds.基于结构的生物活性化合物设计。
Molecules. 2020 Jul 8;25(14):3115. doi: 10.3390/molecules25143115.
Bioorg Med Chem Lett. 2019 Jan 1;29(1):36-39. doi: 10.1016/j.bmcl.2018.11.019. Epub 2018 Nov 9.
4
Required Immunoproteasome Subunit Inhibition Profile for Anti-Inflammatory Efficacy and Clinical Candidate KZR-616 ((2 S,3 R)- N-(( S)-3-(Cyclopent-1-en-1-yl)-1-(( R)-2-methyloxiran-2-yl)-1-oxopropan-2-yl)-3-hydroxy-3-(4-methoxyphenyl)-2-(( S)-2-(2-morpholinoacetamido)propanamido)propenamide).所需免疫蛋白酶体亚单位抑制谱的抗炎疗效和临床候选药物 KZR-616((2 S,3 R)-N-(( S)-3-(环戊-1-烯-1-基)-1-(( R)-2-甲基环氧乙烷-2-基)-1-氧代丙-2-基)-3-羟基-3-(4-甲氧基苯基)-2-(( S)-2-(2-吗啉乙酰胺基)丙氨酰胺基)丙烯酰胺)。
J Med Chem. 2018 Dec 27;61(24):11127-11143. doi: 10.1021/acs.jmedchem.8b01201. Epub 2018 Dec 11.
5
Co-inhibition of immunoproteasome subunits LMP2 and LMP7 is required to block autoimmunity.需要抑制免疫蛋白酶体亚基 LMP2 和 LMP7 的共同作用才能阻断自身免疫。
EMBO Rep. 2018 Dec;19(12). doi: 10.15252/embr.201846512. Epub 2018 Oct 2.
6
Comparative Evaluation of Covalent Docking Tools.共价对接工具的比较评估。
J Chem Inf Model. 2018 Jul 23;58(7):1441-1458. doi: 10.1021/acs.jcim.8b00228. Epub 2018 Jun 22.
7
Piperlongumine and some of its analogs inhibit selectively the human immunoproteasome over the constitutive proteasome.荜茇明碱及其一些类似物对组成型蛋白酶体而言,能选择性地抑制人免疫蛋白酶体。
Biochem Biophys Res Commun. 2018 Feb 12;496(3):961-966. doi: 10.1016/j.bbrc.2018.01.100. Epub 2018 Feb 2.
8
Novel K-Ras G12C Switch-II Covalent Binders Destabilize Ras and Accelerate Nucleotide Exchange.新型 K-Ras G12C 开关 II 型共价结合物使 Ras 失稳并加速核苷酸交换。
J Chem Inf Model. 2018 Feb 26;58(2):464-471. doi: 10.1021/acs.jcim.7b00399. Epub 2018 Jan 31.
9
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma.免疫蛋白酶体选择性和非选择性抑制剂:治疗多发性骨髓瘤的一种有前途的方法。
Pharmacol Ther. 2018 Feb;182:176-192. doi: 10.1016/j.pharmthera.2017.09.001. Epub 2017 Sep 11.
10
Covalent inhibitors design and discovery.共价抑制剂的设计与发现。
Eur J Med Chem. 2017 Sep 29;138:96-114. doi: 10.1016/j.ejmech.2017.06.019. Epub 2017 Jun 10.